speb/financial-data huggingface dataset:
LMR.V balance_sheet (annual, 2025-07-31) — Total Non Current Assets: 11756507.00
LMR.V balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 11756507.00
LMR.V balance_sheet (annual, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LMR.V balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LMR.V income_statement (annual, 2025-07-31) — Total Operating Income As Reported: -1665795.00
LMR.V income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: -447711.00
LMR.V income_statement (annual, 2025-07-31) — Total Unusual Items: -2209414.00
LMR.V income_statement (annual, 2025-07-31) — Total Unusual Items Excluding Goodwill: -2209414.00
LMR.V balance_sheet (annual, 2025-07-31) — Working Capital: 120387.00
LMR.V balance_sheet (quarterly, 2025-07-31) — Working Capital: 120387.00
LMR.V income_statement (quarterly, 2025-10-31) — +Operating Expense: 331783.00
LMR.V income_statement (quarterly, 2025-10-31) — +Total Revenue: 0.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 720595.00
LMR.V income_statement (quarterly, 2025-10-31) — Basic Average Shares: 56178972.00
LMR.V income_statement (quarterly, 2025-10-31) — Basic EPS: -0.01
LMR.V cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 567737.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Capital Stock: 42627032.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 551354.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 551354.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Cash Equivalents: 25000.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Cash Financial: 526354.00
LMR.V cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 323418.00
LMR.V cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -287069.00
LMR.V cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -52732.00
LMR.V cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 220348.00
LMR.V cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: -11917.00
LMR.V cash_flow (quarterly, 2025-10-31) — Change In Receivables: -23915.00
LMR.V cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 184516.00
LMR.V cash_flow (quarterly, 2025-10-31) — Changes In Cash: -16383.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Common Stock: 42627032.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 12470954.00
LMR.V cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 345000.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 144138.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Current Assets: 1985416.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 1084175.00
LMR.V income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 56178972.00
LMR.V income_statement (quarterly, 2025-10-31) — Diluted EPS: -0.01
LMR.V income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — EBIT: -331783.00
LMR.V income_statement (quarterly, 2025-10-31) — EBITDA: -331783.00
LMR.V cash_flow (quarterly, 2025-10-31) — End Cash Position: 551354.00
LMR.V cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 323418.00
LMR.V cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -52732.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 4104956.00
LMR.V income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 267439.00
LMR.V income_statement (quarterly, 2025-10-31) — Insurance And Claims: 5808.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Invested Capital: 12470954.00
LMR.V cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -287069.00
LMR.V cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 345000.00
LMR.V cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 345000.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -323893.00
LMR.V cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -323893.00
LMR.V income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -323893.00
LMR.V cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -21582.00
LMR.V cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: -322069.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Net PPE: 11456969.00
LMR.V cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: 35000.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 12470954.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Non Current Prepaid Assets: 112744.00
LMR.V income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -331783.00
LMR.V income_statement (quarterly, 2025-10-31) — Normalized Income: -323893.00
LMR.V cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -52732.00
LMR.V income_statement (quarterly, 2025-10-31) — Operating Income: -331783.00
LMR.V income_statement (quarterly, 2025-10-31) — Operating Revenue: 0.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 63464044.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 53487.00
LMR.V income_statement (quarterly, 2025-10-31) — Other Gand A: 129293.00
LMR.V income_statement (quarterly, 2025-10-31) — Other Income Expense: 7890.00
LMR.V cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -7890.00
LMR.V income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: 7890.00
LMR.V income_statement (quarterly, 2025-10-31) — Other Operating Expenses: 17281.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Other Payable: 165955.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Other Receivables: 1310084.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Payables: 886550.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 1030688.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 31418.00
LMR.V income_statement (quarterly, 2025-10-31) — Pretax Income: -323893.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Receivables: 1402644.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -34261034.00
LMR.V income_statement (quarterly, 2025-10-31) — Salaries And Wages: 132338.00
LMR.V cash_flow (quarterly, 2025-10-31) — Sale Of PPE: 35000.00
LMR.V income_statement (quarterly, 2025-10-31) — Selling And Marketing Expense: 47063.00
LMR.V income_statement (quarterly, 2025-10-31) — Selling General And Administration: 314502.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Share Issued: 63464044.00
LMR.V cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 94535.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 12470954.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 12470954.00
LMR.V income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
LMR.V income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Taxes Receivable: 92560.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Assets: 13555129.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 12470954.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 12470954.00
LMR.V income_statement (quarterly, 2025-10-31) — Total Expenses: 331783.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 1084175.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 11569713.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LMR.V income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -331783.00
LMR.V balance_sheet (quarterly, 2025-10-31) — Working Capital: 901241.00
LMR.V income_statement (quarterly, 2026-01-31) — +Operating Expense: 635316.00
LMR.V income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 1243982.00
LMR.V income_statement (quarterly, 2026-01-31) — Basic Average Shares: 70130710.00
LMR.V income_statement (quarterly, 2026-01-31) — Basic EPS: -0.01
LMR.V cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 551354.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Capital Stock: 43475298.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 499420.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 499420.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Cash Equivalents: 35000.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Cash Financial: 464420.00
LMR.V cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 1010050.00
LMR.V cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -1763090.00
LMR.V cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 701106.00
LMR.V cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 48869.00
LMR.V cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 13059.00
LMR.V cash_flow (quarterly, 2026-01-31) — Change In Receivables: -107480.00
LMR.V cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 1266340.00
LMR.V cash_flow (quarterly, 2026-01-31) — Changes In Cash: -51934.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Common Stock: 43475298.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 12754749.00
LMR.V cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 1100000.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 376739.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Current Assets: 3277299.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 1311892.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 1311892.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 3244198.00
LMR.V income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 70130710.00
LMR.V income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.01
LMR.V income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — EBIT: -635316.00
LMR.V income_statement (quarterly, 2026-01-31) — EBITDA: -635316.00
LMR.V cash_flow (quarterly, 2026-01-31) — End Cash Position: 499420.00
LMR.V cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 1010050.00
LMR.V cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -542887.00
LMR.V income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 29012.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 3600320.00
LMR.V income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 421950.00
LMR.V income_statement (quarterly, 2026-01-31) — Insurance And Claims: 5726.00
LMR.V income_statement (quarterly, 2026-01-31) — Interest Income: 500.00
LMR.V income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 500.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Invested Capital: 12754749.00
LMR.V cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -1763090.00
LMR.V cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 1100000.00
LMR.V cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 1100000.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -693779.00
LMR.V cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -693779.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Interest Income: 500.00
LMR.V income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 500.00
LMR.V cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -89950.00
LMR.V cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: -484097.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Net PPE: 12721648.00
LMR.V cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -1278993.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 12754749.00
LMR.V income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -539328.00
LMR.V income_statement (quarterly, 2026-01-31) — Normalized Income: -597791.00
LMR.V cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 701106.00
LMR.V income_statement (quarterly, 2026-01-31) — Operating Income: -635316.00
LMR.V income_statement (quarterly, 2026-01-31) — Operating Revenue: 0.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 72630710.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 145630.00
LMR.V income_statement (quarterly, 2026-01-31) — Other Gand A: 292233.00
LMR.V income_statement (quarterly, 2026-01-31) — Other Income Expense: -58963.00
LMR.V cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: -99525.00
LMR.V income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: 37025.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Other Payable: 165955.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Other Receivables: 1408188.00
LMR.V income_statement (quarterly, 2026-01-31) — Other Taxes: 177900.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Payables: 1409937.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 1786676.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 1080096.00
LMR.V income_statement (quarterly, 2026-01-31) — Pretax Income: -693779.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Receivables: 1697783.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -34320869.00
LMR.V income_statement (quarterly, 2026-01-31) — Salaries And Wages: 123991.00
LMR.V income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 35466.00
LMR.V income_statement (quarterly, 2026-01-31) — Selling General And Administration: 457416.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Share Issued: 72630710.00
LMR.V income_statement (quarterly, 2026-01-31) — Special Income Charges: -125000.00
LMR.V cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 103070.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 12754749.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 12754749.00
LMR.V income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
LMR.V income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 289595.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Assets: 15998947.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 12754749.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 12754749.00
LMR.V income_statement (quarterly, 2026-01-31) — Total Expenses: 635316.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 3244198.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 12721648.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LMR.V income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 635316.00
LMR.V income_statement (quarterly, 2026-01-31) — Total Unusual Items: -95988.00
LMR.V income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -95988.00
LMR.V balance_sheet (quarterly, 2026-01-31) — Working Capital: 33101.00
LMR.V income_statement (quarterly, 2026-01-31) — Write Off: 125000.00
LMR.V income_statement (quarterly, 2026-04-30) — +Operating Expense: 493959.00
LMR.V income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 1731506.00
LMR.V cash_flow (quarterly, 2026-04-30) — Asset Impairment Charge: 0.00
LMR.V income_statement (quarterly, 2026-04-30) — Basic Average Shares: 74454618.00
LMR.V income_statement (quarterly, 2026-04-30) — Basic EPS: -0.01
LMR.V cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 499420.00
LMR.V cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -3432479.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Capital Stock: 44149872.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 692701.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 692701.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Cash Equivalents: 25000.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Cash Financial: 667701.00
LMR.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 743621.00
LMR.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: 660557.00
LMR.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -1210897.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Account Payable: -583296.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 0.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Payable: -583296.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -583296.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: 5239.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Receivables: -273563.00
LMR.V cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -851620.00
LMR.V cash_flow (quarterly, 2026-04-30) — Changes In Cash: 193281.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Common Stock: 44149872.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 13078060.00
LMR.V cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 750000.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 311459.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Current Assets: 3333769.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 1311892.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 1311892.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 3568600.00
LMR.V income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 74454618.00
LMR.V income_statement (quarterly, 2026-04-30) — Diluted EPS: -0.01
LMR.V income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — EBIT: -493959.00
LMR.V income_statement (quarterly, 2026-04-30) — EBITDA: -493959.00
LMR.V cash_flow (quarterly, 2026-04-30) — End Cash Position: 692701.00
LMR.V cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 743621.00
LMR.V cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -4643376.00
LMR.V income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 11570.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 3721843.00
LMR.V income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 433517.00
LMR.V income_statement (quarterly, 2026-04-30) — Insurance And Claims: 5787.00
LMR.V income_statement (quarterly, 2026-04-30) — Interest Income: 0.00
LMR.V income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 0.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Invested Capital: 13078060.00
LMR.V cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: 660557.00
LMR.V cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 750000.00
LMR.V cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 750000.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -474548.00
LMR.V cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -474549.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -474548.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Interest Income: 0.00
LMR.V income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 0.00
LMR.V cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -6379.00
LMR.V cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 4093036.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Net PPE: 13312891.00
LMR.V cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -3432479.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 13078060.00
LMR.V income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -505529.00
LMR.V income_statement (quarterly, 2026-04-30) — Normalized Income: -486118.00
LMR.V cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -1210897.00
LMR.V income_statement (quarterly, 2026-04-30) — Operating Income: -493959.00
LMR.V income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 80040396.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 137788.00
LMR.V income_statement (quarterly, 2026-04-30) — Other Gand A: 284899.00
LMR.V income_statement (quarterly, 2026-04-30) — Other Income Expense: 19411.00
LMR.V cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 28409.00
LMR.V income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 7841.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Other Payable: 75955.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Other Receivables: 1092608.00
LMR.V income_statement (quarterly, 2026-04-30) — Other Taxes: 107.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Payables: 1807461.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 2118920.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 1074857.00
LMR.V income_statement (quarterly, 2026-04-30) — Pretax Income: -474548.00
LMR.V cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -3432479.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Receivables: 1566211.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -34793655.00
LMR.V income_statement (quarterly, 2026-04-30) — Salaries And Wages: 142831.00
LMR.V income_statement (quarterly, 2026-04-30) — Selling And Marketing Expense: 60335.00
LMR.V income_statement (quarterly, 2026-04-30) — Selling General And Administration: 493852.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Share Issued: 80040396.00
LMR.V income_statement (quarterly, 2026-04-30) — Special Income Charges: 0.00
LMR.V cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 86863.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 13078060.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 13078060.00
LMR.V income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
LMR.V income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 473603.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Assets: 16646660.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 13078060.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 13078060.00
LMR.V income_statement (quarterly, 2026-04-30) — Total Expenses: 493959.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 3568600.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 13312891.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 0.00
LMR.V income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -493959.00
LMR.V income_statement (quarterly, 2026-04-30) — Total Unusual Items: 11570.00
LMR.V income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 11570.00
LMR.V balance_sheet (quarterly, 2026-04-30) — Working Capital: -234831.00
LMR.V income_statement (quarterly, 2026-04-30) — Write Off: 0.00
LMRI income_statement (annual, 2023-12-31) — +Operating Expense: 111795000.00
LMRI income_statement (annual, 2023-12-31) — +Total Revenue: 935925000.00
LMRI balance_sheet (annual, 2023-12-31) — Accounts Payable: 24413000.00
LMRI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 124124000.00
LMRI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -93119000.00
LMRI income_statement (annual, 2023-12-31) — Amortization: 27400000.00
LMRI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 27400000.00
LMRI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 27400000.00
LMRI income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 27400000.00
LMRI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 18969000.00
LMRI balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 6882000.00
LMRI income_statement (annual, 2023-12-31) — Basic Average Shares: 69412457.00
LMRI income_statement (annual, 2023-12-31) — Basic EPS: -1.76
LMRI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 21098000.00
LMRI balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 851000.00
LMRI cash_flow (annual, 2023-12-31) — Capital Expenditure: -24007000.00
LMRI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 108502000.00
LMRI balance_sheet (annual, 2023-12-31) — Capital Stock: 688283000.00
LMRI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 20186000.00
LMRI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 20186000.00
LMRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -8769000.00
LMRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -29657000.00
LMRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 37514000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Account Payable: 4759000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 22881000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -11441000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -5955000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Payable: 4759000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 27640000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 917000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Receivables: -15297000.00
LMRI cash_flow (annual, 2023-12-31) — Change In Working Capital: -4136000.00
LMRI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -12582000.00
LMRI cash_flow (annual, 2023-12-31) — Changes In Cash: -912000.00
LMRI balance_sheet (annual, 2023-12-31) — Common Stock: 688283000.00
LMRI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 198426000.00
LMRI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 2255000.00
LMRI cash_flow (annual, 2023-12-31) — Common Stock Payments: -118000.00
LMRI balance_sheet (annual, 2023-12-31) — Construction In Progress: 6779000.00
LMRI income_statement (annual, 2023-12-31) — Cost Of Revenue: 836958000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 34614000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Assets: 166767000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 23384000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Debt: 13799000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 37183000.00
LMRI balance_sheet (annual, 2023-12-31) — Current Liabilities: 161115000.00
LMRI cash_flow (annual, 2023-12-31) — Deferred Income Tax: 611000.00
LMRI cash_flow (annual, 2023-12-31) — Deferred Tax: 611000.00
LMRI cash_flow (annual, 2023-12-31) — Depreciation: 72066000.00
LMRI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 72066000.00
LMRI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 56630000.00
LMRI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 72066000.00
LMRI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 56630000.00
LMRI income_statement (annual, 2023-12-31) — Depreciation Income Statement: 29230000.00
LMRI income_statement (annual, 2023-12-31) — Diluted Average Shares: 69412457.00
LMRI income_statement (annual, 2023-12-31) — Diluted EPS: -1.76
LMRI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -122227000.00
LMRI income_statement (annual, 2023-12-31) — EBIT: 22445000.00
LMRI income_statement (annual, 2023-12-31) — EBITDA: 94511000.00
LMRI income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 55527000.00
LMRI cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 4354000.00
LMRI cash_flow (annual, 2023-12-31) — End Cash Position: 20186000.00
LMRI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -8769000.00
LMRI cash_flow (annual, 2023-12-31) — Free Cash Flow: 13507000.00
LMRI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 4984000.00
LMRI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 1285000.00
LMRI income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -1285000.00
LMRI income_statement (annual, 2023-12-31) — General And Administrative Expense: 55165000.00
LMRI balance_sheet (annual, 2023-12-31) — Goodwill: 807554000.00
LMRI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 865927000.00
LMRI balance_sheet (annual, 2023-12-31) — Gross PPE: 288924000.00
LMRI income_statement (annual, 2023-12-31) — Gross Profit: 98967000.00
LMRI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 18969000.00
LMRI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 4749000.00
LMRI income_statement (annual, 2023-12-31) — Interest Expense: 141694000.00
LMRI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 141694000.00
LMRI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 130009000.00
LMRI balance_sheet (annual, 2023-12-31) — Invested Capital: 1394652000.00
LMRI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -29657000.00
LMRI balance_sheet (annual, 2023-12-31) — Investments And Advances: 422461000.00
LMRI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 2255000.00
LMRI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 23934000.00
LMRI balance_sheet (annual, 2023-12-31) — Leases: 55403000.00
LMRI balance_sheet (annual, 2023-12-31) — Limited Partnership Capital: 688283000.00
LMRI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 85118000.00
LMRI balance_sheet (annual, 2023-12-31) — Long Term Debt: 1182427000.00
LMRI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1267545000.00
LMRI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 8934000.00
LMRI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -19840000.00
LMRI balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 422461000.00
LMRI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 25613000.00
LMRI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -5650000.00
LMRI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 2137000.00
LMRI balance_sheet (annual, 2023-12-31) — Net Debt: 1176040000.00
LMRI income_statement (annual, 2023-12-31) — Net Income: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -122227000.00
LMRI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -122227000.00
LMRI income_statement (annual, 2023-12-31) — Net Interest Income: -141694000.00
LMRI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -10906000.00
LMRI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -10906000.00
LMRI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -141694000.00
LMRI balance_sheet (annual, 2023-12-31) — Net PPE: 195805000.00
LMRI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -24007000.00
LMRI cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
LMRI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -667501000.00
LMRI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 22942000.00
LMRI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 22942000.00
LMRI income_statement (annual, 2023-12-31) — Normalized EBITDA: 114765000.00
LMRI income_statement (annual, 2023-12-31) — Normalized Income: -106226340.00
LMRI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 37514000.00
LMRI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 10623000.00
LMRI income_statement (annual, 2023-12-31) — Operating Income: -12828000.00
LMRI income_statement (annual, 2023-12-31) — Operating Revenue: 935925000.00
LMRI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 94565652.00
LMRI balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 13799000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 3143000.00
LMRI income_statement (annual, 2023-12-31) — Other Gand A: 55165000.00
LMRI income_statement (annual, 2023-12-31) — Other Income Expense: 35273000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 58373000.00
LMRI cash_flow (annual, 2023-12-31) — Other Non Cash Items: 6312000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 20567000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 21499000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Payable: 2317000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Properties: 200278000.00
LMRI balance_sheet (annual, 2023-12-31) — Other Receivables: 6131000.00
LMRI balance_sheet (annual, 2023-12-31) — Payables: 27164000.00
LMRI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 61778000.00
LMRI balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 59011000.00
LMRI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 9444000.00
LMRI income_statement (annual, 2023-12-31) — Pretax Income: -119249000.00
LMRI balance_sheet (annual, 2023-12-31) — Properties: 0.00
LMRI cash_flow (annual, 2023-12-31) — Purchase Of Business: -5650000.00
LMRI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -24007000.00
LMRI balance_sheet (annual, 2023-12-31) — Receivables: 130255000.00
LMRI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 821522000.00
LMRI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 72066000.00
LMRI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -34840000.00
LMRI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -118000.00
LMRI balance_sheet (annual, 2023-12-31) — Retained Earnings: -489857000.00
LMRI cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
LMRI cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
LMRI income_statement (annual, 2023-12-31) — Selling General And Administration: 55165000.00
LMRI balance_sheet (annual, 2023-12-31) — Share Issued: 94565652.00
LMRI cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 15000000.00
LMRI cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -15000000.00
LMRI income_statement (annual, 2023-12-31) — Special Income Charges: -20254000.00
LMRI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 55296000.00
LMRI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 198426000.00
LMRI balance_sheet (annual, 2023-12-31) — Tangible Book Value: -667501000.00
LMRI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -4253340.00
LMRI income_statement (annual, 2023-12-31) — Tax Provision: 2978000.00
LMRI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
LMRI balance_sheet (annual, 2023-12-31) — Total Assets: 1671527000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Capitalization: 1380853000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Debt: 1304728000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 198426000.00
LMRI income_statement (annual, 2023-12-31) — Total Expenses: 948753000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1473101000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1504760000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1311986000.00
LMRI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 22445000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Partnership Capital: 198426000.00
LMRI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 434000.00
LMRI income_statement (annual, 2023-12-31) — Total Unusual Items: -20254000.00
LMRI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -20254000.00
LMRI balance_sheet (annual, 2023-12-31) — Working Capital: 5652000.00
LMRI income_statement (annual, 2024-12-31) — +Operating Expense: 112525000.00
LMRI income_statement (quarterly, 2024-12-31) — +Operating Expense: 29972000.00
LMRI income_statement (annual, 2024-12-31) — +Total Revenue: 948869000.00
LMRI income_statement (quarterly, 2024-12-31) — +Total Revenue: 248028000.00
LMRI balance_sheet (annual, 2024-12-31) — Accounts Payable: 29889000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 29889000.00
LMRI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 130354000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 130354000.00
LMRI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -113069000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -113069000.00
LMRI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 745540000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 745540000.00
LMRI income_statement (annual, 2024-12-31) — Amortization: 10600000.00
LMRI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 10600000.00
LMRI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 10600000.00
LMRI income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 10600000.00
LMRI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
LMRI balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
LMRI balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
LMRI income_statement (annual, 2024-12-31) — Basic Average Shares: 94565652.00
LMRI income_statement (annual, 2024-12-31) — Basic EPS: -1.35
LMRI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 20186000.00
LMRI cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 11329000.00
LMRI balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 1445000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 1445000.00
LMRI cash_flow (annual, 2024-12-31) — Capital Expenditure: -27773000.00
LMRI cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -5870000.00
LMRI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 108182000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 108182000.00
LMRI balance_sheet (annual, 2024-12-31) — Capital Stock: 70000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Capital Stock: 70000.00
LMRI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 26131000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 26131000.00
LMRI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 26131000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 26131000.00
LMRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -12499000.00
LMRI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -4926000.00
LMRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -22283000.00
LMRI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -5582000.00
LMRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 40727000.00
LMRI cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 25346000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Account Payable: 2948000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -4040000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 12078000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 26551000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -5952000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -2954000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5440000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 488000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Payable: 2948000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Payable: -4040000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 15026000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 22511000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -911000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 4187000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Receivables: -5323000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Receivables: -6149000.00
LMRI cash_flow (annual, 2024-12-31) — Change In Working Capital: -2600000.00
LMRI cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 18083000.00
LMRI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -6230000.00
LMRI cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -6366000.00
LMRI cash_flow (annual, 2024-12-31) — Changes In Cash: 5945000.00
LMRI cash_flow (quarterly, 2024-12-31) — Changes In Cash: 14802000.00
LMRI balance_sheet (annual, 2024-12-31) — Common Stock: 70000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Common Stock: 70000.00
LMRI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 161654000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 161654000.00
LMRI cash_flow (annual, 2024-12-31) — Common Stock Issuance: 673000.00
LMRI cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 253000.00
LMRI cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
LMRI balance_sheet (annual, 2024-12-31) — Construction In Progress: 6891000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 6891000.00
LMRI income_statement (annual, 2024-12-31) — Cost Of Revenue: 852606000.00
LMRI income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 226456000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 37482000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 37482000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Assets: 172520000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Assets: 172520000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 19316000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 19316000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Debt: 16001000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Debt: 16001000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 35317000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 35317000.00
LMRI balance_sheet (annual, 2024-12-31) — Current Liabilities: 173660000.00
LMRI balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 173660000.00
LMRI cash_flow (annual, 2024-12-31) — Deferred Income Tax: 9753000.00
LMRI cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 6224000.00
LMRI cash_flow (annual, 2024-12-31) — Deferred Tax: 9753000.00
LMRI cash_flow (quarterly, 2024-12-31) — Deferred Tax: 6224000.00
LMRI cash_flow (annual, 2024-12-31) — Depreciation: 57125000.00
LMRI cash_flow (quarterly, 2024-12-31) — Depreciation: 2976000.00
LMRI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 57125000.00
LMRI cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 13576000.00
LMRI income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 42164000.00
LMRI income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 9852000.00
LMRI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 57125000.00
LMRI cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 13576000.00
LMRI income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 42164000.00
LMRI income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 9852000.00
LMRI income_statement (annual, 2024-12-31) — Depreciation Income Statement: 31564000.00
LMRI income_statement (annual, 2024-12-31) — Diluted Average Shares: 94565652.00
LMRI income_statement (annual, 2024-12-31) — Diluted EPS: -1.35
LMRI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -94099000.00
LMRI income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -25058000.00
LMRI income_statement (annual, 2024-12-31) — EBIT: 56834000.00
LMRI income_statement (quarterly, 2024-12-31) — EBIT: 15361000.00
LMRI income_statement (annual, 2024-12-31) — EBITDA: 113959000.00
LMRI income_statement (quarterly, 2024-12-31) — EBITDA: 28937000.00
LMRI income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 71505000.00
LMRI income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 23615000.00
LMRI cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 8026000.00
LMRI cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: -2875000.00
LMRI cash_flow (annual, 2024-12-31) — End Cash Position: 26131000.00
LMRI cash_flow (quarterly, 2024-12-31) — End Cash Position: 26131000.00
LMRI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -12499000.00
LMRI cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -4926000.00
LMRI cash_flow (annual, 2024-12-31) — Free Cash Flow: 12954000.00
LMRI cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 19440000.00
LMRI cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1274000.00
LMRI cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
LMRI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
LMRI cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
LMRI income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 2294000.00
LMRI income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 110000.00